Study of Safety and Immunogenicity of a Quadrivalent Influenza Vaccine in Healthy Adults Age 65-75 Years
NCT02247362
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
200
Enrollment
INDUSTRY
Sponsor class
Conditions
Influenza
Interventions
BIOLOGICAL:
VAX2012Q
OTHER:
Placebo
Sponsor
VaxInnate Corporation